No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Phenobarbital is a central nervous system drug used to treat seizures and insomnia. It is a barbiturate, a type of drug that acts as a sedative-hypnotic. It is also used to treat alcohol withdrawal and to prevent seizures in people with epilepsy. Phenobarbital is available in both generic and brand-name forms. It is typically taken orally, but can also be administered intravenously. Common side effects include drowsiness, dizziness, and confusion.
Phenobarbital is one of the oldest and most widely used anticonvulsant drugs. It is used to treat a variety of seizure disorders, including generalized tonic-clonic seizures, partial seizures, and status epilepticus. It is also used to treat insomnia and alcohol withdrawal.
The phenobarbital market is a part of the larger central nervous system drugs market. This market is driven by the increasing prevalence of neurological disorders, such as epilepsy, Alzheimer's disease, and Parkinson's disease. The market is also driven by the increasing demand for generic drugs, as well as the development of new drugs to treat neurological disorders.
Some companies in the phenobarbital market include Pfizer, GlaxoSmithKline, Sanofi, Novartis, and Mylan. Show Less Read more
